CA2867866C - Methods and kits for assessing central nervous system integrity - Google Patents
Methods and kits for assessing central nervous system integrity Download PDFInfo
- Publication number
- CA2867866C CA2867866C CA2867866A CA2867866A CA2867866C CA 2867866 C CA2867866 C CA 2867866C CA 2867866 A CA2867866 A CA 2867866A CA 2867866 A CA2867866 A CA 2867866A CA 2867866 C CA2867866 C CA 2867866C
- Authority
- CA
- Canada
- Prior art keywords
- eye movement
- subject
- eye
- tracking
- control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 121
- 210000003169 central nervous system Anatomy 0.000 title claims description 14
- 230000004424 eye movement Effects 0.000 claims abstract description 240
- 210000003792 cranial nerve Anatomy 0.000 claims abstract description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 23
- 238000012216 screening Methods 0.000 claims abstract description 17
- 206010022773 Intracranial pressure increased Diseases 0.000 claims abstract description 14
- 201000010099 disease Diseases 0.000 claims abstract description 14
- 238000012544 monitoring process Methods 0.000 claims abstract description 11
- 210000001747 pupil Anatomy 0.000 claims description 40
- 230000000007 visual effect Effects 0.000 claims description 39
- 230000008569 process Effects 0.000 claims description 21
- 208000003906 hydrocephalus Diseases 0.000 claims description 19
- 206010028980 Neoplasm Diseases 0.000 claims description 18
- 208000006011 Stroke Diseases 0.000 claims description 10
- 208000014674 injury Diseases 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- 230000008733 trauma Effects 0.000 claims description 6
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 4
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 4
- 230000000638 stimulation Effects 0.000 claims description 4
- 206010002329 Aneurysm Diseases 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 231100000216 vascular lesion Toxicity 0.000 claims description 3
- 206010026865 Mass Diseases 0.000 claims description 2
- 230000002458 infectious effect Effects 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- 230000001771 impaired effect Effects 0.000 abstract description 19
- 238000007917 intracranial administration Methods 0.000 abstract description 14
- 230000002829 reductive effect Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 description 40
- 238000012360 testing method Methods 0.000 description 40
- 238000002591 computed tomography Methods 0.000 description 37
- 210000004556 brain Anatomy 0.000 description 35
- 230000006870 function Effects 0.000 description 33
- 230000003902 lesion Effects 0.000 description 33
- 230000004433 ocular motility Effects 0.000 description 33
- 238000009826 distribution Methods 0.000 description 28
- 210000005036 nerve Anatomy 0.000 description 27
- 238000007906 compression Methods 0.000 description 26
- 230000006835 compression Effects 0.000 description 26
- 230000033001 locomotion Effects 0.000 description 25
- 210000001328 optic nerve Anatomy 0.000 description 23
- 230000001965 increasing effect Effects 0.000 description 22
- 238000005259 measurement Methods 0.000 description 21
- 238000002271 resection Methods 0.000 description 21
- 201000003077 normal pressure hydrocephalus Diseases 0.000 description 20
- 210000003128 head Anatomy 0.000 description 19
- 238000012545 processing Methods 0.000 description 19
- 238000011160 research Methods 0.000 description 19
- 230000003247 decreasing effect Effects 0.000 description 18
- 230000006872 improvement Effects 0.000 description 18
- 206010033799 Paralysis Diseases 0.000 description 16
- 238000003384 imaging method Methods 0.000 description 15
- 230000002980 postoperative effect Effects 0.000 description 15
- 206010012289 Dementia Diseases 0.000 description 14
- 206010019233 Headaches Diseases 0.000 description 14
- 206010020772 Hypertension Diseases 0.000 description 14
- 231100000869 headache Toxicity 0.000 description 14
- 201000010183 Papilledema Diseases 0.000 description 13
- 206010033712 Papilloedema Diseases 0.000 description 13
- 208000002667 Subdural Hematoma Diseases 0.000 description 13
- 230000007170 pathology Effects 0.000 description 13
- 230000004438 eyesight Effects 0.000 description 12
- 201000009941 intracranial hypertension Diseases 0.000 description 12
- 238000002595 magnetic resonance imaging Methods 0.000 description 12
- 208000021090 palsy Diseases 0.000 description 12
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 11
- 238000007428 craniotomy Methods 0.000 description 11
- 230000005021 gait Effects 0.000 description 11
- 230000000750 progressive effect Effects 0.000 description 11
- 206010046298 Upper motor neurone lesion Diseases 0.000 description 10
- 238000004590 computer program Methods 0.000 description 10
- 210000002589 oculomotor nerve Anatomy 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 210000000133 brain stem Anatomy 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 9
- 208000035475 disorder Diseases 0.000 description 9
- 230000001179 pupillary effect Effects 0.000 description 9
- 208000003164 Diplopia Diseases 0.000 description 8
- 206010019196 Head injury Diseases 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 230000002146 bilateral effect Effects 0.000 description 8
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 8
- 230000006735 deficit Effects 0.000 description 8
- 230000004064 dysfunction Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 206010015769 Extradural haematoma Diseases 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 210000000711 cavernous sinus Anatomy 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000003068 static effect Effects 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 230000004304 visual acuity Effects 0.000 description 7
- 238000012800 visualization Methods 0.000 description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 206010027476 Metastases Diseases 0.000 description 6
- 208000007542 Paresis Diseases 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 6
- 206010062243 Shunt malfunction Diseases 0.000 description 6
- 208000004064 acoustic neuroma Diseases 0.000 description 6
- 208000029028 brain injury Diseases 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 206010019465 hemiparesis Diseases 0.000 description 6
- 201000006370 kidney failure Diseases 0.000 description 6
- 230000009401 metastasis Effects 0.000 description 6
- 208000028173 post-traumatic stress disease Diseases 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 206010010254 Concussion Diseases 0.000 description 5
- 208000019736 Cranial nerve disease Diseases 0.000 description 5
- 230000009514 concussion Effects 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 201000006417 multiple sclerosis Diseases 0.000 description 5
- 230000000926 neurological effect Effects 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 230000004434 saccadic eye movement Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 238000007619 statistical method Methods 0.000 description 5
- 210000002330 subarachnoid space Anatomy 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 4
- 206010017577 Gait disturbance Diseases 0.000 description 4
- 201000002563 Histoplasmosis Diseases 0.000 description 4
- 206010056342 Pulmonary mass Diseases 0.000 description 4
- 208000028979 Skull fracture Diseases 0.000 description 4
- 206010047641 VIth nerve paralysis Diseases 0.000 description 4
- 208000014070 Vestibular schwannoma Diseases 0.000 description 4
- 201000007201 aphasia Diseases 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 229940072645 coumadin Drugs 0.000 description 4
- 201000000133 gait apraxia Diseases 0.000 description 4
- 230000008449 language Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000009593 lumbar puncture Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000000528 statistical test Methods 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 210000001364 upper extremity Anatomy 0.000 description 4
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 206010003805 Autism Diseases 0.000 description 3
- 208000020706 Autistic disease Diseases 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 208000003174 Brain Neoplasms Diseases 0.000 description 3
- 206010015995 Eyelid ptosis Diseases 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010061323 Optic neuropathy Diseases 0.000 description 3
- 208000030886 Traumatic Brain injury Diseases 0.000 description 3
- 210000003208 abducens nerve Anatomy 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000010877 cognitive disease Diseases 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000005713 exacerbation Effects 0.000 description 3
- 210000004055 fourth ventricle Anatomy 0.000 description 3
- 230000003116 impacting effect Effects 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 230000007257 malfunction Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000004899 motility Effects 0.000 description 3
- 208000020911 optic nerve disease Diseases 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 201000003004 ptosis Diseases 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 201000000980 schizophrenia Diseases 0.000 description 3
- 210000003478 temporal lobe Anatomy 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 230000009529 traumatic brain injury Effects 0.000 description 3
- 208000019198 Abducens Nerve disease Diseases 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 208000028698 Cognitive impairment Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 241001269524 Dura Species 0.000 description 2
- 206010013887 Dysarthria Diseases 0.000 description 2
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 2
- 208000023329 Gun shot wound Diseases 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 206010022004 Influenza like illness Diseases 0.000 description 2
- 208000003435 Optic Neuritis Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 206010038934 Retinopathy proliferative Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 208000003028 Stuttering Diseases 0.000 description 2
- 206010042364 Subdural haemorrhage Diseases 0.000 description 2
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 230000008335 axon cargo transport Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000001638 cerebellum Anatomy 0.000 description 2
- 230000007278 cognition impairment Effects 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 229940026692 decadron Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000004023 fresh frozen plasma Substances 0.000 description 2
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 2
- 208000005017 glioblastoma Diseases 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 230000004315 low visual acuity Effects 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000037230 mobility Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000007171 neuropathology Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000008397 ocular pathology Effects 0.000 description 2
- 210000003977 optic chiasm Anatomy 0.000 description 2
- 210000005112 optic tract Anatomy 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 201000010198 papillary carcinoma Diseases 0.000 description 2
- 230000001936 parietal effect Effects 0.000 description 2
- 210000004197 pelvis Anatomy 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 208000005026 persistent vegetative state Diseases 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 210000003281 pleural cavity Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 201000000306 sarcoidosis Diseases 0.000 description 2
- 238000013515 script Methods 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940061353 temodar Drugs 0.000 description 2
- 238000011870 unpaired t-test Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000023529 Abnormality of the optic nerve Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000007333 Brain Concussion Diseases 0.000 description 1
- 208000036632 Brain mass Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010013486 Distractibility Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 206010021283 IIIrd nerve paralysis Diseases 0.000 description 1
- 206010023110 IVth nerve paralysis Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010029174 Nerve compression Diseases 0.000 description 1
- 208000008457 Neurologic Manifestations Diseases 0.000 description 1
- 208000014723 Oculomotor Nerve disease Diseases 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 206010036631 Presenile dementia Diseases 0.000 description 1
- 208000033796 Pseudophakia Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000037132 Subdural Chronic Hematoma Diseases 0.000 description 1
- 241000615754 Tentorium Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 201000007455 central nervous system cancer Diseases 0.000 description 1
- 208000025997 central nervous system neoplasm Diseases 0.000 description 1
- 210000003096 cerebellopontine angle Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007585 cortical function Effects 0.000 description 1
- 230000009537 cortical lesion Effects 0.000 description 1
- 208000014826 cranial nerve neuropathy Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002532 foramen magnum Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000011316 hemodynamic instability Diseases 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000004459 microsaccades Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 230000007991 neuronal integrity Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003565 oculomotor Effects 0.000 description 1
- 201000001909 oculomotor nerve paralysis Diseases 0.000 description 1
- 206010030875 ophthalmoplegia Diseases 0.000 description 1
- 238000002577 ophthalmoscopy Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000005019 pattern of movement Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000004439 pupillary reactions Effects 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000003863 superior colliculi Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013520 translational research Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/113—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining or recording eye movement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/0016—Operational features thereof
- A61B3/0025—Operational features thereof characterised by electronic signal processing, e.g. eye models
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/02—Subjective types, i.e. testing apparatus requiring the active assistance of the patient
- A61B3/024—Subjective types, i.e. testing apparatus requiring the active assistance of the patient for determining the visual field, e.g. perimeter types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Human Computer Interaction (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Eye Examination Apparatus (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615463P | 2012-03-26 | 2012-03-26 | |
| US61/615,463 | 2012-03-26 | ||
| US201261710213P | 2012-10-05 | 2012-10-05 | |
| US61/710,213 | 2012-10-05 | ||
| PCT/US2013/033672 WO2013148557A1 (en) | 2012-03-26 | 2013-03-25 | Methods and kits for assessing central nervous system integrity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2867866A1 CA2867866A1 (en) | 2013-10-03 |
| CA2867866C true CA2867866C (en) | 2022-06-21 |
Family
ID=49261144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2867866A Active CA2867866C (en) | 2012-03-26 | 2013-03-25 | Methods and kits for assessing central nervous system integrity |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US9642522B2 (enExample) |
| EP (1) | EP2830479B1 (enExample) |
| JP (2) | JP6559062B2 (enExample) |
| CN (1) | CN104780828B (enExample) |
| AU (1) | AU2013239981B2 (enExample) |
| BR (1) | BR112014023637B1 (enExample) |
| CA (1) | CA2867866C (enExample) |
| WO (1) | WO2013148557A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10463248B2 (en) * | 2011-03-02 | 2019-11-05 | Brien Holden Vision Institute Limited | Systems, methods, and devices for measuring eye movement and pupil response |
| BR112014023637B1 (pt) | 2012-03-26 | 2021-12-21 | New York University | Métodos para avaliação da integridade do sistema nervoso central e para detecção, diagnóstico ou avaliação de pressão intracraniana aumentada |
| AU2014281725B2 (en) * | 2013-06-17 | 2019-10-10 | New York University | Methods and kits for assessing neurological and ophthalmic function and localizing neurological lesions |
| US9895100B2 (en) | 2013-10-04 | 2018-02-20 | Indiana University Research And Technology Corporation | Eye movement monitoring of brain function |
| JP6287486B2 (ja) * | 2014-03-31 | 2018-03-07 | 富士通株式会社 | 情報処理装置、方法及びプログラム |
| US20150307048A1 (en) * | 2014-04-23 | 2015-10-29 | Creative Inovation Services, LLC | Automobile alert information system, methods, and apparatus |
| JP2017529891A (ja) * | 2014-08-04 | 2017-10-12 | ニューヨーク ユニバーシティ | 薬物使用、薬物乱用および昏睡、核間性眼筋麻痺、注意欠陥多動性障害（ａｄｈｄ）、慢性外傷性脳症、統合失調症スペクトラム障害、およびアルコール摂取を診断、評価、または定量化するための方法およびキット |
| US10231617B2 (en) * | 2014-08-21 | 2019-03-19 | Dignity Health | Systems and methods for using eye movements to determine traumatic brain injury |
| US10045730B2 (en) * | 2014-09-11 | 2018-08-14 | The Mitre Corporation | Methods and systems for rapid screening of mild traumatic brain injury |
| US20170042462A1 (en) * | 2015-08-10 | 2017-02-16 | Neuro Kinetics, Inc. | Automated Data Acquisition, Appraisal and Analysis in Noninvasive Rapid Screening of Neuro-Otologic Conditions Using Combination of Subject's Objective Oculomotor Vestibular and Reaction Time Analytic Variables |
| CA2901477C (en) | 2015-08-25 | 2023-07-18 | Evolution Optiks Limited | Vision correction system, method and graphical user interface for implementation on electronic devices having a graphical display |
| US11064881B2 (en) | 2015-11-13 | 2021-07-20 | Hennepin Healthcare System, Inc | Method for predicting convergence disorders caused by concussion or other neuropathology |
| JP6693105B2 (ja) * | 2015-12-01 | 2020-05-13 | 株式会社Ｊｖｃケンウッド | 視線検出装置及び視線検出方法 |
| WO2017127798A1 (en) | 2016-01-22 | 2017-07-27 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Ocular cranial nerve monitoring system |
| EP3493728B1 (en) | 2016-08-02 | 2025-11-05 | New York University | Methods and kits for assessing neurological function and localizing neurological lesions |
| US10863902B2 (en) * | 2016-10-03 | 2020-12-15 | Oculogica Inc. | Method for detecting glaucoma |
| TWI602068B (zh) * | 2016-10-17 | 2017-10-11 | Data processing device and method thereof | |
| US10201274B2 (en) | 2016-10-20 | 2019-02-12 | Oculogica Inc | Eye tracking system with biometric identification |
| US11141095B2 (en) | 2017-02-17 | 2021-10-12 | Oculogica Inc. | Method and system for detecting concussion |
| CN114403802A (zh) * | 2017-09-13 | 2022-04-29 | 奥库洛吉卡公司 | 眼睛跟踪系统 |
| CA3086037A1 (en) * | 2017-11-30 | 2019-06-06 | Viewmind S.A. | System and method for detecting neurological disorders and for measuring general cognitive performance |
| EP3781066A4 (en) * | 2018-04-20 | 2022-01-05 | The United States Government as represented by the Department of Veterans Affairs | PROCESSES AND KITS FOR THE OPTIMIZATION OF NEUROSURGICAL INTERVENTION SITE |
| US12290373B2 (en) | 2018-04-27 | 2025-05-06 | C. Light Technologies, Inc. | Method of detection, prognostication, and monitoring of neurological disorders |
| JP6945493B2 (ja) * | 2018-05-09 | 2021-10-06 | 富士フイルム株式会社 | 医用画像処理装置、方法およびプログラム |
| KR102250999B1 (ko) | 2018-06-29 | 2021-05-12 | 고려대학교 산학협력단 | 시야장애 평가 및 안구 운동장애 평가 결과에 기반한 뇌병변 진단 장치 |
| US11327563B2 (en) | 2018-10-22 | 2022-05-10 | Evolution Optiks Limited | Light field vision-based testing device, adjusted pixel rendering method therefor, and online vision-based testing management system and method using same |
| US11500460B2 (en) | 2018-10-22 | 2022-11-15 | Evolution Optiks Limited | Light field device, optical aberration compensation or simulation rendering |
| US11966507B2 (en) | 2018-10-22 | 2024-04-23 | Evolution Optiks Limited | Light field vision testing device, adjusted pixel rendering method therefor, and vision testing system and method using same |
| US11500461B2 (en) | 2019-11-01 | 2022-11-15 | Evolution Optiks Limited | Light field vision-based testing device, system and method |
| WO2020219711A1 (en) | 2019-04-23 | 2020-10-29 | Evolution Optiks Limited | Light field display and vibrating light field shaping layer and vision testing and/or correction device |
| US11635617B2 (en) | 2019-04-23 | 2023-04-25 | Evolution Optiks Limited | Digital display device comprising a complementary light field display or display portion, and vision correction system and method using same |
| US11902498B2 (en) | 2019-08-26 | 2024-02-13 | Evolution Optiks Limited | Binocular light field display, adjusted pixel rendering method therefor, and vision correction system and method using same |
| US11823598B2 (en) | 2019-11-01 | 2023-11-21 | Evolution Optiks Limited | Light field device, variable perception pixel rendering method therefor, and variable perception system and method using same |
| US11487361B1 (en) | 2019-11-01 | 2022-11-01 | Evolution Optiks Limited | Light field device and vision testing system using same |
| US12360592B2 (en) | 2019-11-01 | 2025-07-15 | Evolution Optiks Limited | Light field device and vision testing system using same |
| US12112665B2 (en) | 2019-11-01 | 2024-10-08 | Evolution Optiks Limited | Light field device, variable perception pixel rendering method therefor, and variable perception system and method using same |
| CN110897608B (zh) * | 2019-12-15 | 2022-05-03 | 深圳市具安科技有限公司 | 斑马鱼眼动分析方法、装置及计算机设备 |
| JP7565566B2 (ja) * | 2020-11-24 | 2024-10-11 | 学校法人東京医科大学 | 身体状態の推定装置、身体状態の推定装置の作動方法、プログラム、および記録媒体 |
| US12390172B2 (en) | 2021-02-19 | 2025-08-19 | Canon Medical Systems Corporation | Method and apparatus for displaying medical images |
| US11429188B1 (en) * | 2021-06-21 | 2022-08-30 | Sensie, LLC | Measuring self awareness utilizing a mobile computing device |
| WO2023281622A1 (ja) * | 2021-07-06 | 2023-01-12 | 日本電気株式会社 | 回復度推定装置、回復度推定方法、及び、記録媒体 |
| JP7711753B2 (ja) * | 2021-07-06 | 2025-07-23 | 日本電気株式会社 | 回復度推定装置、回復度推定方法、及び、プログラム |
| WO2024013546A1 (en) * | 2022-07-12 | 2024-01-18 | Mcdowell Nicola Jean | A method of identifying a higher visual perceptual difficulty |
| WO2025034122A1 (en) * | 2023-08-04 | 2025-02-13 | VRF Vault Limited | Methods and systems for assessing the presence of traumatic brain injury |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4576184A (en) | 1981-08-31 | 1986-03-18 | Pharmometrics Corporation | Drug abuse detection |
| US4889422A (en) | 1986-01-28 | 1989-12-26 | George Pavlidis | Method and means for detecting dyslexia |
| US4838681A (en) | 1986-01-28 | 1989-06-13 | George Pavlidis | Method and means for detecting dyslexia |
| US6622036B1 (en) * | 2000-02-09 | 2003-09-16 | Cns Response | Method for classifying and treating physiologic brain imbalances using quantitative EEG |
| US20020024633A1 (en) | 1999-04-09 | 2002-02-28 | Daehoon Kim | Pupil evaluation system |
| US6247813B1 (en) * | 1999-04-09 | 2001-06-19 | Iritech, Inc. | Iris identification system and method of identifying a person through iris recognition |
| US6820979B1 (en) * | 1999-04-23 | 2004-11-23 | Neuroptics, Inc. | Pupilometer with pupil irregularity detection, pupil tracking, and pupil response detection capability, glaucoma screening capability, intracranial pressure detection capability, and ocular aberration measurement capability |
| US6116736A (en) | 1999-04-23 | 2000-09-12 | Neuroptics, Inc. | Pupilometer with pupil irregularity detection capability |
| US6346887B1 (en) | 1999-09-14 | 2002-02-12 | The United States Of America As Represented By The Secretary Of The Navy | Eye activity monitor |
| EP1246667B1 (en) | 1999-12-30 | 2005-03-23 | Medtronic, Inc. | User authentication in medical device systems |
| BR0108476A (pt) | 2000-02-11 | 2003-04-22 | Marcio Marc Abreu | Sistema e método para comunicar informação de revocação de produto, advertências relacionadas ao produto ou outra informação relacionada aos usuários de produtos |
| US20020169364A1 (en) * | 2000-02-14 | 2002-11-14 | Baumzweiger William E. | Brainstem and limbic disorder (BALD) |
| US6652458B2 (en) | 2000-06-20 | 2003-11-25 | The Mclean Hospital Corporation | ADHD detection by eye saccades |
| EP1219243A1 (en) | 2000-12-28 | 2002-07-03 | Matsushita Electric Works, Ltd. | Non-invasive brain function examination |
| DE10132378A1 (de) | 2001-07-06 | 2003-04-24 | Zeiss Carl Meditec Ag | Verfahren und Vorrichtung zur Verfolgung von Augenbewegungen |
| JP4543594B2 (ja) | 2001-07-31 | 2010-09-15 | パナソニック電工株式会社 | 脳機能検査装置および脳機能検査システム |
| US8211031B2 (en) * | 2002-01-15 | 2012-07-03 | Orsan Medical Technologies Ltd. | Non-invasive intracranial monitor |
| US7147605B2 (en) * | 2002-07-08 | 2006-12-12 | Uab Vittamed | Method and apparatus for noninvasive determination of the absolute value of intracranial pressure |
| US7575321B2 (en) * | 2003-10-30 | 2009-08-18 | Welch Allyn, Inc. | Apparatus and method of diagnosis of optically identifiable ophthalmic conditions |
| DE60323410D1 (de) | 2003-11-30 | 2008-10-16 | Volvo Technology Corp | Verfahren und system zum erkennen einer fahrerbeeinträchtigung |
| US7384399B2 (en) | 2004-02-11 | 2008-06-10 | Jamshid Ghajar | Cognition and motor timing diagnosis and training system and method |
| US7819818B2 (en) * | 2004-02-11 | 2010-10-26 | Jamshid Ghajar | Cognition and motor timing diagnosis using smooth eye pursuit analysis |
| CN102670163B (zh) | 2004-04-01 | 2016-04-13 | 威廉·C·托奇 | 控制计算装置的系统及方法 |
| WO2007075460A2 (en) | 2005-12-16 | 2007-07-05 | Novavision, Inc. | Adjustable device for vision testing and therapy |
| WO2007070953A1 (en) * | 2005-12-20 | 2007-06-28 | Neuro Vision Technology Pty Ltd | Apparatus and method for assessment and rehabilitation after acquired brain injury |
| US7535991B2 (en) | 2006-10-16 | 2009-05-19 | Oraya Therapeutics, Inc. | Portable orthovoltage radiotherapy |
| WO2009052833A1 (en) | 2007-10-23 | 2009-04-30 | Mindmetic Ltd. | Method, system and computer program for automated interpretation of measurements in response to stimuli |
| CA2704777C (en) * | 2007-11-01 | 2017-09-12 | Catholic Healthcare West | Method of detecting neurological disease |
| WO2009085204A2 (en) | 2007-12-23 | 2009-07-09 | Oraya Therapeutics, Inc. | Methods and devices for detecting, controlling, and predicting radiation delivery |
| US8265743B2 (en) * | 2007-12-27 | 2012-09-11 | Teledyne Scientific & Imaging, Llc | Fixation-locked measurement of brain responses to stimuli |
| WO2010006180A1 (en) * | 2008-07-09 | 2010-01-14 | Mckinley Laurence M | Optic function monitoring process and apparatus |
| WO2010042557A2 (en) | 2008-10-06 | 2010-04-15 | Neuro Kinetics, Inc. | Method and apparatus for corrective secondary saccades analysis with video oculography system |
| WO2010062400A1 (en) | 2008-11-28 | 2010-06-03 | Neuroptics, Inc. | Methods, systems, and devices for monitoring anisocoria and asymmetry of pupillary reaction to stimulus |
| US8808195B2 (en) * | 2009-01-15 | 2014-08-19 | Po-He Tseng | Eye-tracking method and system for screening human diseases |
| US20100280372A1 (en) * | 2009-05-03 | 2010-11-04 | Pieter Poolman | Observation device and method |
| GB0917600D0 (en) * | 2009-10-07 | 2009-11-25 | Univ Edinburgh | Testing apparatus and method |
| US9229227B2 (en) | 2010-02-28 | 2016-01-05 | Microsoft Technology Licensing, Llc | See-through near-eye display glasses with a light transmissive wedge shaped illumination system |
| US8732795B2 (en) | 2010-05-21 | 2014-05-20 | Epic Systems Corporation | System and method for user authentication |
| US9691289B2 (en) * | 2010-12-22 | 2017-06-27 | Brightstar Learning | Monotonous game-like task to promote effortless automatic recognition of sight words |
| CA2827498C (en) | 2011-01-28 | 2020-09-22 | Dignity Health | Method of detecting neurological disease |
| CA2754835C (en) | 2011-10-07 | 2021-06-15 | Baycrest Centre For Geriatric Care | Methods and systems for assessing cognitive function |
| ITVR20110201A1 (it) * | 2011-11-02 | 2013-05-03 | Milano Politecnico | Dispositivo per il monitoraggio della posizione e deimovimenti dell'occhio, particolarmente adatto per la radioterapia oculare |
| US9078612B2 (en) | 2011-12-02 | 2015-07-14 | Third Eye Diagnostics, Inc. | Devices and methods for noninvasive measurement of intracranial pressure |
| US20130208952A1 (en) | 2012-02-13 | 2013-08-15 | Geoffrey Auchinleck | Method and Apparatus for Improving Accuracy of Biometric Identification in Specimen Collection Applications |
| BR112014023637B1 (pt) | 2012-03-26 | 2021-12-21 | New York University | Métodos para avaliação da integridade do sistema nervoso central e para detecção, diagnóstico ou avaliação de pressão intracraniana aumentada |
| US9101312B2 (en) | 2012-04-18 | 2015-08-11 | TBI Diagnostics LLC | System for the physiological evaluation of brain function |
| US8668337B2 (en) | 2012-04-18 | 2014-03-11 | TBI Diagnostics LLC | System for the physiological evaluation of brain function |
| US9004687B2 (en) | 2012-05-18 | 2015-04-14 | Sync-Think, Inc. | Eye tracking headset and system for neuropsychological testing including the detection of brain damage |
| US8808179B1 (en) | 2012-08-06 | 2014-08-19 | James Z. Cinberg | Method and associated apparatus for detecting minor traumatic brain injury |
| US8585589B1 (en) | 2012-08-06 | 2013-11-19 | James Z. Cinberg | Method and associated apparatus for detecting minor traumatic brain injury |
| US8951046B2 (en) | 2012-08-10 | 2015-02-10 | Sync-Think, Inc. | Desktop-based opto-cognitive device and system for cognitive assessment |
| US10085688B2 (en) | 2012-11-20 | 2018-10-02 | El-Mar Inc. | Method of identifying an individual with a disorder or efficacy of a treatment of a disorder |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| BR112015022523A2 (pt) | 2013-03-11 | 2017-07-18 | Childrens Healthcare Atlanta Inc | sistemas e métodos para detecção de condições de desenvolvimento e cognitivas |
| US9247870B2 (en) * | 2013-03-15 | 2016-02-02 | Neuro Kinetics, Inc. | Method and apparatus for system synchronization in video oculography based neuro-otologic testing and evaluation |
| AU2014281725B2 (en) | 2013-06-17 | 2019-10-10 | New York University | Methods and kits for assessing neurological and ophthalmic function and localizing neurological lesions |
| US9895100B2 (en) | 2013-10-04 | 2018-02-20 | Indiana University Research And Technology Corporation | Eye movement monitoring of brain function |
| ES2848833T3 (es) | 2013-10-17 | 2021-08-12 | Childrens Healthcare Atlanta Inc | Métodos para valorar el desarrollo de bebés y niños por medio de seguimiento de ojos |
| US9958939B2 (en) | 2013-10-31 | 2018-05-01 | Sync-Think, Inc. | System and method for dynamic content delivery based on gaze analytics |
| US9721476B2 (en) | 2013-11-06 | 2017-08-01 | Sync-Think, Inc. | System and method for dynamic cognitive training |
| US9459451B2 (en) | 2013-12-26 | 2016-10-04 | Microsoft Technology Licensing, Llc | Eye tracking apparatus, method and system |
| WO2015164807A1 (en) | 2014-04-25 | 2015-10-29 | Texas State University | Detection of brain injury and subject state with eye movement biometrics |
| JP6550460B2 (ja) | 2014-05-09 | 2019-07-24 | グーグル エルエルシー | 眼信号を識別するためのシステムおよび方法、ならびに連続バイオメトリック認証 |
| WO2016009334A1 (en) | 2014-07-17 | 2016-01-21 | Bitoun Pierre | Measurement of ocular parameters using vibrations induced in the eye |
| JP2017529891A (ja) | 2014-08-04 | 2017-10-12 | ニューヨーク ユニバーシティ | 薬物使用、薬物乱用および昏睡、核間性眼筋麻痺、注意欠陥多動性障害（ａｄｈｄ）、慢性外傷性脳症、統合失調症スペクトラム障害、およびアルコール摂取を診断、評価、または定量化するための方法およびキット |
| WO2016090376A1 (en) | 2014-12-05 | 2016-06-09 | Texas State University | Eye tracking via patterned contact lenses |
| US20160213248A1 (en) | 2015-01-22 | 2016-07-28 | Ovard, Llc | Gaze stabilization system and method |
| US20170091392A1 (en) | 2015-05-01 | 2017-03-30 | Steven C. White | Biometric identification telemedicine software |
| US11064881B2 (en) | 2015-11-13 | 2021-07-20 | Hennepin Healthcare System, Inc | Method for predicting convergence disorders caused by concussion or other neuropathology |
| US10863902B2 (en) | 2016-10-03 | 2020-12-15 | Oculogica Inc. | Method for detecting glaucoma |
| US10201274B2 (en) | 2016-10-20 | 2019-02-12 | Oculogica Inc | Eye tracking system with biometric identification |
| US11141095B2 (en) | 2017-02-17 | 2021-10-12 | Oculogica Inc. | Method and system for detecting concussion |
-
2013
- 2013-03-25 BR BR112014023637-2A patent/BR112014023637B1/pt active IP Right Grant
- 2013-03-25 AU AU2013239981A patent/AU2013239981B2/en active Active
- 2013-03-25 EP EP13770301.3A patent/EP2830479B1/en active Active
- 2013-03-25 JP JP2015503430A patent/JP6559062B2/ja active Active
- 2013-03-25 WO PCT/US2013/033672 patent/WO2013148557A1/en not_active Ceased
- 2013-03-25 US US14/387,892 patent/US9642522B2/en active Active
- 2013-03-25 CA CA2867866A patent/CA2867866C/en active Active
- 2013-03-25 CN CN201380027719.8A patent/CN104780828B/zh active Active
-
2017
- 2017-02-10 US US15/429,413 patent/US10219694B2/en active Active
-
2018
- 2018-04-12 JP JP2018077014A patent/JP2018143779A/ja active Pending
-
2019
- 2019-01-29 US US16/260,379 patent/US11304601B2/en active Active
-
2022
- 2022-03-17 US US17/697,860 patent/US12201361B2/en active Active
-
2024
- 2024-12-13 US US18/979,814 patent/US20250107709A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220202289A1 (en) | 2022-06-30 |
| US20250107709A1 (en) | 2025-04-03 |
| BR112014023637B1 (pt) | 2021-12-21 |
| US20190150732A1 (en) | 2019-05-23 |
| US20150190050A1 (en) | 2015-07-09 |
| WO2013148557A9 (en) | 2014-11-27 |
| EP2830479B1 (en) | 2021-11-17 |
| US11304601B2 (en) | 2022-04-19 |
| EP2830479A1 (en) | 2015-02-04 |
| CA2867866A1 (en) | 2013-10-03 |
| JP2018143779A (ja) | 2018-09-20 |
| CN104780828B (zh) | 2017-10-27 |
| AU2013239981B2 (en) | 2017-07-06 |
| US20170340204A1 (en) | 2017-11-30 |
| US10219694B2 (en) | 2019-03-05 |
| AU2013239981A1 (en) | 2014-10-09 |
| CN104780828A (zh) | 2015-07-15 |
| WO2013148557A1 (en) | 2013-10-03 |
| US12201361B2 (en) | 2025-01-21 |
| JP2015512299A (ja) | 2015-04-27 |
| EP2830479A4 (en) | 2015-11-25 |
| JP6559062B2 (ja) | 2019-08-14 |
| BR112014023637A2 (pt) | 2017-06-20 |
| US9642522B2 (en) | 2017-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12201361B2 (en) | Methods and kits for assessing central nervous system integrity | |
| US20250057486A1 (en) | Methods And Kits For Assessing Neurological And Ophthalmic Function And Localizing Neurological Lesions | |
| US11944449B2 (en) | Methods and kits for assessing neurological function and localizing neurological lesions | |
| US11013441B2 (en) | Methods and kits for diagnosing, assessing or quantitating drug use, drug abuse and narcosis, internuclear ophthalmoplegia, attention deficit hyperactivity disorder (ADHD), chronic traumatic encephalopathy, schizophrenia spectrum disorders and alcohol consumption | |
| Kelly et al. | Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180220 |
|
| EEER | Examination request |
Effective date: 20180220 |